| Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation Y Kondo, L Shen, AS Cheng, S Ahmed, Y Boumber, C Charo, T Yamochi, ... Nature genetics 40 (6), 741-750, 2008 | 705 | 2008 |
| Downregulation of histone H3 lysine 9 methyltransferase G9a induces centrosome disruption and chromosome instability in cancer cells Y Kondo, L Shen, S Ahmed, Y Boumber, Y Sekido, BR Haddad, JPJ Issa PloS one 3 (4), e2037, 2008 | 285 | 2008 |
| Biomarkers for immune checkpoint inhibition in non–small cell lung cancer (NSCLC) JN Bodor, Y Boumber, H Borghaei Cancer 126 (2), 260-270, 2020 | 263 | 2020 |
| NCCN guidelines insights: small cell lung cancer, version 2.2018 GP Kalemkerian, BW Loo, W Akerley, A Attia, M Bassetti, Y Boumber, ... Journal of the National Comprehensive Cancer Network 16 (10), 1171-1182, 2018 | 249 | 2018 |
| Musashi RNA-binding proteins as cancer drivers and novel therapeutic targets AE Kudinov, J Karanicolas, EA Golemis, Y Boumber Clinical Cancer Research 23 (9), 2143-2153, 2017 | 249 | 2017 |
| Existing and emerging biomarkers for immune checkpoint immunotherapy in solid tumors S Arora, R Velichinskii, RW Lesh, U Ali, M Kubiak, P Bansal, H Borghaei, ... Advances in therapy 36, 2638-2678, 2019 | 182 | 2019 |
| Epigenetics in cancer: what's the future? MD Yanis Boumber, JPJ Issa Oncology 25 (3), 220, 2011 | 166 | 2011 |
| Musashi-2 (MSI2) supports TGF-β signaling and inhibits claudins to promote non-small cell lung cancer (NSCLC) metastasis AE Kudinov, A Deneka, AS Nikonova, TN Beck, YH Ahn, X Liu, ... Proceedings of the National Academy of Sciences 113 (25), 6955-6960, 2016 | 131 | 2016 |
| Drug sensitivity prediction by CpG island methylation profile in the NCI-60 cancer cell line panel L Shen, Y Kondo, S Ahmed, Y Boumber, K Konishi, Y Guo, X Chen, ... Cancer research 67 (23), 11335-11343, 2007 | 123 | 2007 |
| Mocetinostat (MGCD0103): a review of an isotype-specific histone deacetylase inhibitor Y Boumber, A Younes, G Garcia-Manero Expert opinion on investigational drugs 20 (6), 823-829, 2011 | 104 | 2011 |
| Chromatin remodeling is required for gene reactivation after decitabine-mediated DNA hypomethylation J Si, YA Boumber, J Shu, T Qin, S Ahmed, R He, J Jelinek, JPJ Issa Cancer research 70 (17), 6968-6977, 2010 | 99 | 2010 |
| RIL, a LIM gene on 5q31, is silenced by methylation in cancer and sensitizes cancer cells to apoptosis YA Boumber, Y Kondo, X Chen, L Shen, V Gharibyan, K Konishi, E Estey, ... Cancer research 67 (5), 1997-2005, 2007 | 99 | 2007 |
| An Sp1/Sp3 binding polymorphism confers methylation protection YA Boumber, Y Kondo, X Chen, L Shen, Y Guo, C Tellez, MRH Estécio, ... PLoS genetics 4 (8), e1000162, 2008 | 83 | 2008 |
| Tumor mutational burden (TMB) as a biomarker of response to immunotherapy in small cell lung cancer Y Boumber Journal of thoracic disease 10 (8), 4689, 2018 | 74 | 2018 |
| Epigenetic inactivation of Notch-Hes pathway in human B-cell acute lymphoblastic leukemia SQ Kuang, Z Fang, PA Zweidler-McKay, H Yang, Y Wei, ... PloS one 8 (4), e61807, 2013 | 66 | 2013 |
| Anti-Müllerian hormone signaling regulates epithelial plasticity and chemoresistance in lung cancer TN Beck, VA Korobeynikov, AE Kudinov, R Georgopoulos, NR Solanki, ... Cell reports 16 (3), 657-671, 2016 | 64 | 2016 |
| A phase I/II study of the mTOR inhibitor everolimus in combination with HyperCVAD chemotherapy in patients with relapsed/refractory acute lymphoblastic leukemia N Daver, Y Boumber, H Kantarjian, F Ravandi, J Cortes, ME Rytting, ... Clinical Cancer Research 21 (12), 2704-2714, 2015 | 64 | 2015 |
| A randomized study of decitabine versus conventional care for maintenance therapy in patients with acute myeloid leukemia in complete remission Y Boumber, H Kantarjian, J Jorgensen, S Wen, S Faderl, R Castoro, ... Leukemia 26 (11), 2428-2431, 2012 | 64 | 2012 |
| Circulating tumor cell and cell-free RNA capture and expression analysis identify platelet-associated genes in metastatic lung cancer TN Beck, YA Boumber, C Aggarwal, J Pei, C Thrash-Bingham, P Fittipaldi, ... BMC cancer 19 (1), 1-13, 2019 | 41 | 2019 |
| The convergent roles of NF-κB and ER stress in sunitinib-mediated expression of pro-tumorigenic cytokines and refractory phenotype in renal cell carcinoma P Makhov, S Naito, M Haifler, A Kutikov, Y Boumber, RG Uzzo, ... Cell death & disease 9 (3), 374, 2018 | 39 | 2018 |
Erica GolemisProfessor, Assoc. Director for System Integration, Fox Chase Cancer Center, and Chair, LKSOMVerified email at fccc.edu
